Abstract:Background: An increase in deaths has been perceived during the pandemic, which cannot be explained only by COVID-19. The actual number of deaths far exceeds the recorded data on deaths directly related to SARS-CoV-2 infection. Data from early and short-lived pandemic studies show a dramatic shift in cardiovascular mortality. Grounded in the post-pandemic era, macroscopic big data on cardiovascular mortality during the pandemic need to be further reviewed and studied, which is crucial for cardiovascular disease prevention and control. Methods: We retrieved and collected data associated with cardiovascular disease mortality from the National Vital Statistic System from the Center for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research (CDC WONDER) platform based on the ICD-10 codes. We applied regression analysis to characterize overall cardiovascular disease mortality trends from 2010 to 2023 and built a time series model to predict mortality for 2020–2023 based on mortality data from 2010 to 2019 in order to affirm the existence of the excess deaths by evaluating observed vs. predicted mortality. We also conducted subgroup analyses by sex, age and race/ethnicity for the purpose of obtaining more specific sociodemographic information. Results: All-cause age-standardised mortality rates (ASMRs) for CVD dramatically increased between 2019 and 2021[annual percentage change (APC) 11.27%, p < 0.01], and then decreased in the following 2021–2023(APC: −7.0%, p < 0.01). Subgroup analyses found that the ASMR change was most pronounced in Alaska Indians/Native American people (APC: 16.5% in 2019–2021, −12.5% in 2021–2023, both p < 0.01), Hispanics (APC: 12.1% in 2019–2021, −12.2% in 2021–2023, both p < 0.05) and non-Hispanic Black people (APC:11.8% in 2019–2021, −10.3% in 2021–2023, both p < 0.01)whether during the increasing or declining phase. Similarly, the ASMR change was particularly dramatic for the 25–44 age group (APC:19.8% in 2019–2021, −15.4% in 2021–2023, both p < 0.01) and males (APC: 11.5% in 2019–2021, −7.6% in 2021–2023, both p < 0.01). By the end of 2023, the proportion of COVID-related excess death remained high among the elderly (22.4%), males (42.8%) and Alaska Indians/Native American people(39.7%). In addition, we did not find the presence of excess deaths in the young (25–44) and middle-aged cohort (45–64) in 2023, while excess deaths remained persistent in the elderly. Conclusions: All-cause ASMRs for CVD increased notably during the initial two years of the COVID-19 pandemic and then witnessed a decline in 2021–2023. The cohorts (the young, males and minorities) with the steepest rise in mortality decreased at the fastest rate instead. Previous initiatives to promote cardiovascular health were effective, but further research on cardiovascular healthcare for the elderly and racial disparities should be attached to priority considering the presence of sociodemographic differences in CVD death.

Examination of Gender Difference in Heart Disease-Related Excess Deaths during COVID-19 Pandemic Era: Findings from the United States

Abstract 11754: Trends in Cardiovascular Mortality Before and During the COVID-19 Pandemic

Insights into Covid-19 Mortality: A Comprehensive Study of Cardiovascular Sensitivity, Gender, Race, and Geography Trends in the United States (2020-2023)

Gender disparity between authors in leading medical journals during the COVID-19 pandemic: a cross-sectional review

Excess Risk for Acute Myocardial Infarction Mortality During the COVID-19 Pandemic

Health risks and outcomes that disproportionately affect women during the Covid-19 pandemic: A review

Gender Disparities in Authorship of Invited Manuscripts During the COVID-19 Pandemic

Impact of the COVID-19 pandemic on cardiovascular mortality and contrast analysis within subgroups

Gender disparity in the authorship of biomedical research publications during the COVID-19 pandemic

Unraveling Disparities: Probing Gender, Race, and Geographic Inequities in Pulmonary Heart Disease Mortality in the United States: An Extensive Longitudinal Examination (1999-2020) Leveraging CDC WONDER Data

Gender Differences in Hospital Outcomes among COVID-19 Hospitalizations

Sex-Based Disparities in Acute Myocardial Infarction Treatment Patterns and Outcomes in Older Adults Hospitalized Across 6 High-Income Countries: An Analysis From the International Health Systems Research Collaborative

Gender differences in COVID-19 attitudes and behavior: Panel evidence from eight countries

Gender imbalance in gynecologic oncology authorship and impact of COVID-19 pandemic

Impact of COVID-19 on the cardiovascular health of women: a review by the Italian Society of Cardiology Working Group on 'gender cardiovascular diseases'

The Uneven Access to COVID-19 Research for Women in Science

Abstract 58: Socioeconomically Driven Reversal of Mortality Trends Among Patients With Primary Intracerebral Hemorrhage During the COVID-19 Pandemic: An Analysis of Nationally Representative Data

Further divided gender gaps in research productivity and collaboration during the COVID-19 pandemic: Evidence from coronavirus-related literature

Gender differences in COVID-19 preventative measures and vaccination rates in the United States: A longitudinal survey analysis

Sex Differences in Long-Term Cardiovascular Outcomes and Mortality After COVID-19 Hospitalization During Alpha, Delta and Omicron Waves

Sex differences in acute myocardial infarction - Preliminary results from an umbrella review